<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03541759</url>
  </required_header>
  <id_info>
    <org_study_id>5/18-Anesthesiology</org_study_id>
    <nct_id>NCT03541759</nct_id>
  </id_info>
  <brief_title>Pain Management After Elective Shoulder Surgery</brief_title>
  <official_title>Pain Management After Elective Shoulder Surgery: A Randomized Quantitative Study Comparing Hydromorphone With Piritramide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Austrian Workers’ Compensation Board Trauma Center Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Austrian Workers’ Compensation Board Trauma Center Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain management plays an important role in elective shoulder surgery. The aim
      of this randomized quantitative study is to compare two frequently used postoperative pain
      regimes (hydromorphone versus piritramide) regarding onset and duration after the
      effectiveness of the single-shot interscalene block has diminished.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2018</start_date>
  <completion_date type="Actual">May 17, 2018</completion_date>
  <primary_completion_date type="Actual">May 15, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain management after elective shoulder surgery</measure>
    <time_frame>6 months</time_frame>
    <description>Comparison of hydromorphone versus piritramide using the numeric rating scale (NRS; range 0 - 10 points; level 0 representing no pain; level 10 representing the highest pain level)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Hydromorphone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydromorphone Hcl 4 milligram (mg) Tab 2 times after surgery as basic medication. Hydromorphone Hcl 2.6mg maximum 2 per 24h when numeric rating scale (NRS) &gt; 5.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Piritramide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Piritramide 15mg s.c. 2 times after surgery as basic medication. Piritramide 7.5mg s.c. maximum 2 per 24h when numeric rating scale (NRS) &gt; 5.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydromorphone Hcl 4Mg Tab</intervention_name>
    <description>Hydal retard 4Mg Tab 2 times after surgery as basic medication. Hydal retard 2.6Mg maximum 2 per 24h when NRS &gt; 5.</description>
    <arm_group_label>Hydromorphone</arm_group_label>
    <other_name>Hydal retard 4Mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piritramide 15mg s.c.</intervention_name>
    <description>Dipidolor 15mg s.c. 2 times after surgery as basic medication. Dipidolor 7.5mg s.c. maximum 2 per 24h when NRS &gt; 5.</description>
    <arm_group_label>Piritramide</arm_group_label>
    <other_name>Dipidolor 15mg s.c.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients undergoing elective shoulder surgery with a single-shot interscalene
             plexus brachialis block in addition to general anesthesia

          -  patients aged 18-99 years

          -  patients being capable of giving an informed consent to participation in this study

        Exclusion Criteria:

          -  patients aged below 18 years

          -  patients with decompensated liver, heart or renal insufficiency

          -  patients with any kind of lung disease

          -  patients with a chronic pain syndrome

          -  patients with a previous pain medication with more than 3 drugs over more than 3
             months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heinz Steltzer, MD, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Trauma Center Vienna Meidling</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Austrian Workers Compensation Board Trauma Center Vienna Meidling</name>
      <address>
        <city>Vienna</city>
        <zip>1120</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2018</study_first_posted>
  <last_update_submitted>May 31, 2018</last_update_submitted>
  <last_update_submitted_qc>May 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Austrian Workers’ Compensation Board Trauma Center Vienna</investigator_affiliation>
    <investigator_full_name>Sandra Boesmueller, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Elective shoulder surgery, hydromorphone, piritramide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydromorphone</mesh_term>
    <mesh_term>Pirinitramide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

